Zenazocine (INN; WIN-42,964) is an opioid analgesic of the benzomorphan family which made it to phase II clinical trials before development was ultimately halted and it was never marketed. It acts as a partial agonist of the μ- and δ-opioid receptors, with less intrinsic activity at the former receptor and more at the latter receptor (hence, it behaves more antagonistically at the former and more agonistically at the latter), and produces antinociceptive effects in animal studies.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Zenazocina (it)
- Zenazocine (en)
|
rdfs:comment
| - La zenazocine (INN; WIN-42,964) è un oppioide analgesico derivante dalla famiglia del benzomorfano che ha raggiunto la fase III nei test clinici prima che il suo sviluppo venisse definitivamente bloccato e mai messo sul mercato. Agisce come agonista parziale dei recettori μ- e δ-oppioidi, con minore attività intrinseca sui primi e maggiore sui secondi (pertanto agisce in misura preponderante come antagonista sui primi e come agonista sui secondi), e produce effetti nocicettivi su test animali. (it)
- Zenazocine (INN; WIN-42,964) is an opioid analgesic of the benzomorphan family which made it to phase II clinical trials before development was ultimately halted and it was never marketed. It acts as a partial agonist of the μ- and δ-opioid receptors, with less intrinsic activity at the former receptor and more at the latter receptor (hence, it behaves more antagonistically at the former and more agonistically at the latter), and produces antinociceptive effects in animal studies. (en)
|
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
ATC prefix
| |
c
| |
CAS number
| |
ChemSpiderID
| |
H
| |
image
| - Zenazocine-3D-balls-by-AHRLS-2012.png (en)
|
IUPAC name
| |
legal status
| |
n
| |
O
| |
PubChem
| |
SMILES
| |
StdInChI
| |
StdInChIKey
| - JZFZEWWOIOYBTQ-AXWGZAFASA-N (en)
|
UNII
| |
has abstract
| - La zenazocine (INN; WIN-42,964) è un oppioide analgesico derivante dalla famiglia del benzomorfano che ha raggiunto la fase III nei test clinici prima che il suo sviluppo venisse definitivamente bloccato e mai messo sul mercato. Agisce come agonista parziale dei recettori μ- e δ-oppioidi, con minore attività intrinseca sui primi e maggiore sui secondi (pertanto agisce in misura preponderante come antagonista sui primi e come agonista sui secondi), e produce effetti nocicettivi su test animali. (it)
- Zenazocine (INN; WIN-42,964) is an opioid analgesic of the benzomorphan family which made it to phase II clinical trials before development was ultimately halted and it was never marketed. It acts as a partial agonist of the μ- and δ-opioid receptors, with less intrinsic activity at the former receptor and more at the latter receptor (hence, it behaves more antagonistically at the former and more agonistically at the latter), and produces antinociceptive effects in animal studies. (en)
|
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
CAS number
| |
FDA UNII code
| |
PubChem
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is foaf:primaryTopic
of | |